Return to Clinical Trials Search Results

ORACLE Registry Dr. Biswas Biodesix Nodify XL2

Primary Outcome Measures : Statistically significant change in the proportion of benign lung nodules managed by BDX-XL2 experiencing invasive procedures. [ Time Frame: Up to 2 years ]